Literature DB >> 28025599

Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Junling Wang1, Yanru Qiao2, Christina A Spivey3, Christine Li4, Caroline Clark5, Yuewen Deng6, Flora Liu7, Jeffrey Tillman8, Marie Chisholm-Burns9.   

Abstract

OBJECTIVES: Previous studies found that racial and ethnic minorities may be less likely than non-Hispanic Whites (Whites) to meet existing Medicare medication therapy management (MTM) eligibility criteria. To address these issues, the Centers for Medicare & Medicaid Services (CMS) proposed alternative Medicare MTM eligibility criteria for 2015. Due to opposition to other Part D reforms proposed simultaneously by various stakeholders, CMS rescinded all proposed reforms. This study was conducted to determine whether non-Hispanic Blacks (Blacks) and Hispanics have lower likelihood of meeting the proposed 2015 Medicare MTM eligibility criteria.
METHODS: This retrospective observational analysis used Medical Expenditure Panel Survey data (2010-2011). The final study sample was comprised of 2,721 Whites (weighted to 37,185,896), 917 Blacks (weighted to 4,665,644), and 538 Hispanics (weighted to 3,532,882). Chi-square tests were used to examine racial and ethnic disparities in meeting proposed 2015 MTM eligibility criteria and each component of proposed 2015 MTM eligibility criteria. In multivariate analysis, a logistic regression model was used to control for population socio-demographic and health-related characteristics. KEY
FINDINGS: Compared to Whites with a proportion of MTM eligibility of 58.82%, the eligible proportion was 57.09% (P=0.20) for Blacks, and 48.97% (P<0.0001) for Hispanics, respectively. According to multivariate logistic regression, odds ratios of meeting MTM eligibility for Blacks and Hispanics compared to Whites were 0.74 (95% Confidence Internal [CI] = 0.62-0.88) and 0.53 (95% CI=0.43-0.67), respectively.
CONCLUSIONS: The proposed 2015 MTM eligibility criteria would not eliminate racial and ethnic disparities in MTM eligibility. Alternative MTM eligibility criteria should be devised.

Entities:  

Keywords:  Medicare; Race; eligibility; ethnicity; medication therapy management services

Year:  2016        PMID: 28025599      PMCID: PMC5181845          DOI: 10.1111/jphs.12142

Source DB:  PubMed          Journal:  J Pharm Health Serv Res        ISSN: 1759-8885


  26 in total

1.  Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Authors:  Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins
Journal:  Med Care Res Rev       Date:  2006-12       Impact factor: 3.929

2.  Disparities in health care: minority elders at risk.

Authors:  Lisa Byrd; Audwin Fletcher; Charles Menifield
Journal:  ABNF J       Date:  2007

3.  Medicare backs off on MTM changes: congressional and patient-group opposition to other, more controversial part d reforms sank the plan.

Authors:  Stephen Barlas
Journal:  P T       Date:  2014-07

4.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

Review 5.  Toward a fourth generation of disparities research to achieve health equity.

Authors:  Stephen B Thomas; Sandra Crouse Quinn; James Butler; Craig S Fryer; Mary A Garza
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

6.  Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.

Authors:  Gregory W Daniel; Daniel C Malone
Journal:  J Manag Care Pharm       Date:  2007-03

7.  Historical trend of disparity implications of Medicare MTM eligibility criteria.

Authors:  Junling Wang; Yanru Qiao
Journal:  Res Social Adm Pharm       Date:  2012-10-10

8.  Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman
Journal:  Res Social Adm Pharm       Date:  2013-06-10

Review 9.  Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.

Authors:  Kiraat D Munshi; Ya-Chen T Shih; Lawrence M Brown; Samuel Dagogo-Jack; Jim Y Wan; Junling Wang
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-04       Impact factor: 2.217

10.  Racial disparities in prescription drug use among dually eligible beneficiaries.

Authors:  Jennifer Schore; Randall Brown; Bridget Lavin
Journal:  Health Care Financ Rev       Date:  2003
View more
  7 in total

1.  Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.

Authors:  Christina A Spivey; Yanru Qiao; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Marie A Chisholm-Burns
Journal:  J Am Geriatr Soc       Date:  2019-01-23       Impact factor: 5.562

2.  Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.

Authors:  Xiaobei Dong; Chi Chun Steve Tsang; Shirong Zhao; Jim Y Wan; Ya-Chen Tina Shih; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Junling Wang
Journal:  Am Health Drug Benefits       Date:  2021-09

3.  Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.

Authors:  Jamie A Browning; Chi Chun Steve Tsang; Rose Zeng; Xiaobei Dong; Joseph Garuccio; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Junling Wang
Journal:  Curr Med Res Opin       Date:  2022-08-09       Impact factor: 2.705

4.  Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2018-09-07

5.  Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

6.  Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.

Authors:  Jamie A Browning; Chi Chun Steve Tsang; Xiaobei Dong; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Colin Liu; Junling Wang
Journal:  BMC Health Serv Res       Date:  2022-02-07       Impact factor: 2.655

7.  Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.

Authors:  Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Manag Care Spec Pharm       Date:  2018-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.